Atticus Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-605
Closed -$159K 439
2025
Q2
$159K Buy
605
+329
+119% +$80.1K 0.04% 190
2025
Q1
$64.2K Hold
276
0.02% 208
2024
Q4
$63.3K Hold
276
0.02% 221
2024
Q3
$61.7K Hold
276
0.02% 226
2024
Q2
$56.2K Sell
276
-1
-0.4% -$203 0.02% 224
2024
Q1
$60.5K Sell
277
-1
-0.4% -$220 0.02% 224
2023
Q4
$63.2K Hold
278
0.02% 220
2023
Q3
$55.9K Sell
278
-46
-14% -$9.7K 0.02% 233
2023
Q2
$67.1K Hold
324
0.02% 225
2023
Q1
$63.8K Sell
324
-53
-14% -$10.9K 0.02% 222
2022
Q4
$76.3K Sell
377
-5
-1% -$977 0.03% 204
2022
Q3
$77K Hold
382
0.04% 191
2022
Q2
$77K Buy
382
+321
+526% +$68.4K 0.03% 211
2022
Q1
$14K Buy
61
+5
+9% +$1.18K 0.01% 373
2021
Q4
$15K Hold
56
0.01% 333
2021
Q3
$14K Sell
56
-495
-90% -$125K 0.01% 333
2021
Q2
$130K Hold
551
0.06% 146
2021
Q1
$121K Sell
551
-7
-1% -$1.41K 0.06% 143
2020
Q4
$98K Buy
+558
New +$96.4K 0.05% 157

Other funds holding LH

Atticus Wealth Management's LH Position: Q3 2025 in Review

Atticus Wealth Management sold out of Labcorp (LH) in Q3 2025, closing a stake of 605 shares — an estimated $159K sold.

Atticus Wealth Management first reported a position in LH in Q4 2020 and held it in 19 quarters. The position peaked at $159K in Q2 2025. 1,010 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Atticus Wealth Management reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 605 Labcorp shares in Q3 2025, an estimated $159K.
  • Atticus Wealth Management first reported a position in Labcorp in Q4 2020 and held it in 19 quarters.
  • Atticus Wealth Management's Labcorp position peaked at $159K in Q2 2025.
  • 1,010 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.